RAS Pathway Mutations As Predictive Biomarker for Treatment Adaptation in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

被引：3
|
作者：
Jerchel, Isabel S. [1 ]
Hoogkamer, Alex Q. [1 ]
Aries, Ingrid M. [1 ]
Steeghs, Elisabeth M. P. [1 ]
Boer, Judith M. [1 ]
Besselink, Nicolle J. M. [2 ,3 ]
Boeree, Aurelie [1 ]
van de Ven, Cesca [1 ]
de Groot-Kruseman, Hester A. [4 ]
De Haas, Valerie [4 ]
Horstmann, Martin A. [5 ]
Escherich, Gabriele [5 ]
Stam, Ronald W. [1 ]
Zwaan, C. Michel [1 ]
Cuppen, Edwin [2 ,3 ]
Koudijs, Marco J. [2 ,3 ]
Pieters, Rob [4 ,6 ]
Den Boer, Monique L. [1 ,4 ]
机构：
[1] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands
[2] Univ Med Ctr Utrecht, Ctr Personalized Canc Treatment, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Div Biomed Genet, Ctr Mol Med Canc Genom Netherlands, Utrecht, Netherlands
[4] Dutch Childhood Oncol Grp, The Hague, Netherlands
[5] Univ Med Ctr Hamburg Eppendorf, German Cooperat Study Grp Childhood Acute Lymphob, Hamburg, Germany
[6] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.4087.4087
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4087
引用
收藏
页数：6
相关论文
共 50 条
  • [1] RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
    I S Jerchel
    A Q Hoogkamer
    I M Ariës
    E M P Steeghs
    J M Boer
    N J M Besselink
    A Boeree
    C van de Ven
    H A de Groot-Kruseman
    V de Haas
    M A Horstmann
    G Escherich
    C M Zwaan
    E Cuppen
    M J Koudijs
    R Pieters
    M L den Boer
    Leukemia, 2018, 32 : 931 - 940
  • [2] RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
    Jerchel, I. S.
    Hoogkamer, A. Q.
    Aries, I. M.
    Steeghs, E. M. P.
    Boer, J. M.
    Besselink, N. J. M.
    Boeree, A.
    van de Ven, C.
    de Groot-Kruseman, H. A.
    de Haas, V.
    Horstmann, M. A.
    Escherich, G.
    Zwaan, C. M.
    Cuppen, E.
    Koudijs, M. J.
    Pieters, R.
    den Boer, M. L.
    LEUKEMIA, 2018, 32 (04) : 931 - 940
  • [3] Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia
    Ueno, Hiroo
    Yoshida, Kenichi
    Shiozawa, Yusuke
    Nannya, Yasuhito
    Iijima-Yamashita, Yuka
    Kiyokawa, Nobutaka
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Isobe, Tomoya
    Seki, Masafumi
    Kimura, Shunsuke
    Makishima, Hideki
    Nakagawa, Masahiro M.
    Kakiuchi, Nobuyuki
    Kataoka, Keisuke
    Yoshizato, Tetsuichi
    Nishijima, Dai
    Deguchi, Takao
    Ohki, Kentaro
    Sato, Atsushi
    Takahashi, Hiroyuki
    Hashii, Yoshiko
    Tokimasa, Sadao
    Hara, Junichi
    Kosaka, Yoshiyuki
    Kato, Koji
    Inukai, Takeshi
    Takita, Junko
    Imamura, Toshihiko
    Miyano, Satoru
    Manabe, Atsushi
    Horibe, Keizo
    Ogawa, Seishi
    Sanada, Masashi
    BLOOD ADVANCES, 2020, 4 (20) : 5165 - 5173
  • [4] Cobalamin deficiency during treatment of pediatric precursor B-cell acute lymphoblastic leukemia
    Kinoshita, Hiromi
    Watanabe, Atsuko
    Taji, Yoshitada
    Yoshimura, Moe
    Ohta, Atsuhiko
    Fukushima, Takashi
    Tanaka, Ryuhei
    Ebihara, Yasuhiro
    PEDIATRIC BLOOD & CANCER, 2021, 68 (12)
  • [5] The Majority of RAS Pathway Mutations Detected in Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia Are Present in Major or Minor Subclones at Diagnosis
    Yu, Jiangyan
    Waanders, Esme
    van Reijmersdal, Simon V.
    Sonneveld, Edwin
    Hoogerbrugge, Peter M.
    van Leeuwen, Frank N.
    van Kessel, Ad Geurts
    Kuiper, Roland P.
    BLOOD, 2014, 124 (21)
  • [6] Genetic Profiling of Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
    Akin-Bali, Dilara Fatma
    Erdogan, Beyza Doganay
    Oner, Deniz Aslar
    Mahmud, Akkan
    Tasdelen, Serpil
    Kurekci, Emin
    Akar, Nejat
    Sevgili, Hilal Ozdag
    JOURNAL OF PEDIATRIC GENETICS, 2023, 12 (04) : 288 - 300
  • [7] New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia
    Lilljebjorn, Henrik
    Fioretos, Thoas
    BLOOD, 2017, 130 (12) : 1395 - 1401
  • [8] Biomarker profile for prediction of response to SMAC mimetic monotherapy in pediatric precursor B-cell acute lymphoblastic leukemia
    Zinngrebe, Julia
    Schlichtig, Ferdinand
    Kraus, Johann M.
    Meyer, Malcolm
    Boldrin, Elena
    Kestler, Hans A.
    Meyer, Lueder-Hinrich
    Fischer-Posovszky, Pamela
    Debatin, Klaus-Michael
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (11) : 3219 - 3231
  • [9] Molecular characterization and biomarker identification in pediatric B-cell acute lymphoblastic leukemia
    Du, Yu
    Zhang, Xiankai
    Sun, Ming
    Yang, Li
    Long, Fei
    Qi, Shanshan
    Luo, Linlin
    Wang, Chenxuan
    Lv, Xiaoyan
    Wu, Xiaoying
    Zhu, Liuqing
    Ou, Qiuxiang
    Xiong, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Biomarker Profile for Prediction of Patient Response to Smac Mimetic Monotherapy in Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia
    Zinngrebe, Julia
    Schlichtig, Ferdinand
    Meyer, Malcolm
    Kraus, Johann M.
    Boldrin, Elena
    Kestler, Hans A.
    Meyer, Luder Hinrich
    Fischer-Posovszky, Pamela
    Debatin, Klaus-Michael
    BLOOD, 2019, 134
12345